Previous findings demonstrated that G-1 treatment induced p53 expression, and p53 knockdown partially reversed G-1–dependent anticancer effects in breast cancer cells (24), suggesting that p53 is a downstream mediator of GPER. Here, TP53 is linked to breast cancer.